Literature DB >> 34422692

An outbreak of ertapenem-resistant, carbapenemase-negative and porin-deficient ESBL-producing Klebsiella pneumoniae complex.

Mihaela Matovina1, Maja Abram2, Davorka Repac-Antić3, Samira Knežević4, Marina Bubonja-Šonje2.   

Abstract

INTRODUCTION: Carbapenem-resistant Klebsiella pneumoniae is an emerging healthcare-associated pathogen with dynamic molecular epidemiology. This study presents a retrospective analysis of the distribution and antibiotic resistance patterns of ertapenem-resistant ESBL-producing K. pneumoniae strains recovered during an outbreak from 2012 to 2014 in a Croatian University hospital.
METHODS: We aimed to estimate genetic relatedness of clinical isolates and underlying mechanisms that conferred the ertapenem-resistant phenotype.
RESULTS: Expression analysis of genes involved in the antibiotic resistance showed reduced expression of major non-selective porin channel OmpK35. Reduced expression of OmpK36 porin channel in isolates resistant to at least one more carbapenem, apart from the ertapenem, was found to a lesser degree. Pulsed-field gel electrophoresis analysis of genomic DNA revealed that almost all isolates belonged to the same genetic clone.
CONCLUSIONS: Caution regarding ertapenem-resistant, carbapenemase-negative porin-deficient mutants of K. pneumoniae is required as they are widespread, and under selective pressure this could result in a local clonal outbreak. GERMS.

Entities:  

Keywords:  Ertapenem; Klebsiella pneumoniae; drug resistance; molecular epidemiology; outbreak

Year:  2021        PMID: 34422692      PMCID: PMC8373410          DOI: 10.18683/germs.2021.1257

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  29 in total

1.  Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.

Authors:  Michael W Pfaffl; Graham W Horgan; Leo Dempfle
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

2.  Tigecycline-non-susceptible hypervirulent Klebsiella pneumoniae strains in Taiwan.

Authors:  Yi-Hsiang Cheng; Tzu-Wen Huang; Chih-Han Juan; Sheng-Hua Chou; Yao-Yi Tseng; Ting-Wen Chen; Tsuey-Ching Yang; Yi-Tsung Lin
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

3.  Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.

Authors:  Valentino D'Onofrio; Rick Conzemius; Dijana Varda-Brkić; Maja Bogdan; Andrea Grisold; Inge C Gyssens; Branka Bedenić; Ivan Barišić
Journal:  Infect Genet Evol       Date:  2020-02-24       Impact factor: 3.342

4.  Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.

Authors:  Etsuko Sugawara; Seiji Kojima; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2016-11-04       Impact factor: 3.490

5.  Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.

Authors:  Aggeliki Poulou; Evangelia Voulgari; Georgia Vrioni; Vasiliki Koumaki; Grigorios Xidopoulos; Vasiliki Chatzipantazi; Fani Markou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

6.  Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia.

Authors:  B Bedenic; Z Zagar
Journal:  J Chemother       Date:  1998-12       Impact factor: 1.714

7.  Rapid detection of carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Laurent Poirel; Laurent Dortet
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

8.  NDM-1-producing Klebsiella pneumoniae, Croatia.

Authors:  Annarita Mazzariol; Zrinka Bošnjak; Piero Ballarini; Ana Budimir; Branka Bedenić; Smilja Kalenić; Giuseppe Cornaglia
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

Review 9.  Carbapenem-Resistant Klebsiella pneumoniae: Microbiology Key Points for Clinical Practice.

Authors:  Jorge Reyes; Ana Cristina Aguilar; Andrés Caicedo
Journal:  Int J Gen Med       Date:  2019-11-28

10.  Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria.

Authors:  Amol T Kothekar; Jigeeshu Vasishtha Divatia; Sheila Nainan Myatra; Anand Patil; Manjunath Nookala Krishnamurthy; Harish Mallapura Maheshwarappa; Suhail Sarwar Siddiqui; Murari Gurjar; Sanjay Biswas; Vikram Gota
Journal:  Ann Intensive Care       Date:  2020-01-10       Impact factor: 6.925

View more
  1 in total

1.  Urinary tract infections in children: clinical and antimicrobial resistance data from Bucharest area, Romania.

Authors:  Victor Daniel Miron; Claudiu Filimon; Teodor Cabel; Roxana Ioana Mihăescu; Gabriela Bar; Denisa Leu; Mihai Craiu
Journal:  Germs       Date:  2021-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.